Financials Evaxion A/S

Equities

EVAX

US29970R3030

Biotechnology & Medical Research

Market Closed - Nasdaq Other stock markets 00:00:00 12/03/2026 +04			5-day change	1st Jan Change
3.870 ^USD	+8.10%		+24.44%	-18.87%

03-10	European Equities Traded in the US as American Depositary Receipts Rise in Tuesday Trading	MT
03-09	European Equities Traded in the US as American Depositary Receipts Decline in Monday Trading	MT

Projected Income Statement: Evaxion A/S

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Net sales ¹	-	-	-	3.344	7.528	3.958	16.95	16.02
Change	-	-	-	-	125.12%	-47.42%	328.18%	-5.45%
EBITDA	-25.49	-24.61	-21.58	-	-	-	-	-
Change	-	3.45%	12.3%	-	-	-	-	-
EBIT ¹	-25.83	-25.26	-22.2	-14.73	-9.234	-13.19	-1.507	-5.154
Change	-	2.21%	12.14%	33.63%	37.32%	-42.79%	88.57%	-241.93%
Interest Paid ¹	-0.915	-1.508	-1.681	-3.123	-	-3.222	-3.194	-0.332
Earnings before Tax (EBT) ¹	-24.71	-23.94	-22.92	-11.36	-8.615	-13.3	-1.604	-5.265
Change	-	3.11%	4.29%	50.45%	24.13%	-54.33%	87.94%	-228.22%
Net income ¹	-24.53	-23.17	-22.12	-10.57	-7.707	-13.05	-1.606	-6.927
Change	-	5.56%	4.51%	52.24%	27.07%	-69.27%	87.69%	-331.47%
Announcement Date	22/03/22	27/04/23	26/03/24	01/04/25	05/03/26	-	-	-

¹USD in Million

Estimates

Fiscal Period: December	2021 Q1	2021 Q2	2021 Q3	2021 Q4	2022 Q1	2022 Q2	2022 Q3	2022 Q4	2023 Q1	2023 Q2	2023 Q3	2023 Q4	2024 Q1	2024 Q2	2024 Q3	2024 Q4	2025 Q1	2025 Q2	2025 Q3	2025 Q4	2026 Q1	2026 Q2	2026 Q3	2026 Q4	2027 Q1	2027 Q2	2027 Q3	2027 Q4
Net sales ¹	-	-	-	-	-	-	-	-	-	-	-	-	0.051	0.154	3.017	0.122	-	0.037	7.492	-	-	-	-	-	-	-	-	-
Change	-	-	-	-	-	-	-	-	-	-	-	-	-	201.96%	1,859.09%	-95.96%	-	-	20,148.65%	-	-	-	-	-	-	-	-	-
EBITDA	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Change	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
EBIT ¹	-5.175	-7.026	-5.912	-7.721	-6.399	-6.259	-6.083	-6.525	-6.394	-5.677	-5.762	-4.364	-4.396	-4.581	-1.731	-4.024	-3.868	-4.34	3.022	-4.052	-3.981	-4.071	-4.286	-4.409	-4.595	-4.795	-5.194	-5.394
Change	-	-35.77%	15.86%	-30.6%	17.12%	2.19%	2.81%	-7.27%	2.01%	11.21%	-1.5%	24.26%	-0.73%	-4.21%	62.21%	-132.47%	3.88%	-12.2%	169.63%	-234.08%	1.75%	-2.27%	-5.26%	-2.89%	-4.21%	-4.35%	-8.32%	-3.85%
Charge d'intérêts ¹	-	-	-	-	-0.158	-0.225	-0.535	-0.59	-0.326	-0.278	-0.182	-0.895	-0.246	-2.036	-0.384	-0.458	-0.397	-1.232	-1.36	-	-1.5	-1.5	-1.5	-1.5	-	-	-	-
Earnings before Tax (EBT) ¹	-4.5	-7.488	-5.675	-7.047	-6.038	-4.945	-5.915	-7.045	-6.435	-5.908	-5.872	-4.7	0.976	-6.397	-2.031	-3.904	-1.772	-5.026	4.352	-6.173	-3.981	-4.071	-4.286	-4.409	-4.595	-4.795	-5.194	-5.394
Change	-	-66.4%	24.21%	-24.18%	14.32%	18.1%	-19.62%	-19.1%	8.66%	8.19%	0.61%	19.96%	120.77%	-755.43%	68.25%	-92.22%	54.61%	-183.63%	186.59%	-241.84%	35.51%	-2.27%	-5.26%	-2.89%	-4.21%	-4.35%	-8.32%	-3.85%
Net income ¹	-4.093	-6.819	-5.25	-8.37	-5.791	-4.768	-5.74	-6.872	-6.241	-5.683	-5.678	-4.523	1.194	-6.198	-1.935	-3.629	-1.58	-4.831	4.618	-5.918	-3.881	-3.971	-4.186	-4.309	-4.595	-4.795	-5.194	-5.394
Change	-	-66.6%	23.01%	-59.43%	30.81%	17.67%	-20.39%	-19.72%	9.18%	8.94%	0.09%	20.34%	126.4%	-619.1%	68.78%	-87.55%	56.46%	-205.76%	195.59%	-228.15%	34.42%	-2.33%	-5.4%	-2.95%	-6.63%	-4.35%	-8.32%	-3.85%
Announcement Date	13/05/21	12/08/21	09/11/21	22/03/22	11/05/22	10/08/22	14/11/22	27/04/23	31/05/23	17/08/23	19/12/23	26/03/24	28/05/24	14/08/24	31/10/24	01/04/25	27/05/25	14/08/25	06/11/25	05/03/26	-	-	-	-	-	-	-	-

¹USD in Million

Estimates

Fiscal Period: December	2025 S1	2025 S2	2026 S1	2026 S2
Net sales ¹	0.037	7.491	9.2	6.7
Change	-	20,145.95%	22.81%	-27.17%
EBITDA	-	-	-	-
Change	-	-	-	-
EBIT ¹	-	-1.026	-0.036	-2.997
Change	-	-7.41%	96.49%	-8,225%
Charge d'intérêts ¹	-	-0.391	-0.369	-0.369
Earnings before Tax (EBT) ¹	-	-1.817	-0.405	-3.365
Change	-	17.83%	77.71%	-730.86%
Net income ¹	-	-1.296	-0.405	-3.365
Change	-	-15.2%	68.75%	-730.86%
Announcement Date	14/08/25	05/03/26	-	-

¹USD in Million

Estimates

Forecast Balance Sheet: Evaxion A/S

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Net Debt	-28.5	-	-	-	-	-	-	-
Change	-	-	-	-	-	-	-	-
Announcement Date	22/03/22	27/04/23	26/03/24	01/04/25	05/03/26	-	-	-

Estimates

Cash Flow Forecast: Evaxion A/S

Fiscal Period: December	2021	2022	2026	2027	2028
CAPEX ¹	1.3	0.292	-	-	-
Change	-	-77.54%	-	-	-
Free Cash Flow (FCF) ¹	-23.23	-26.07	-15.59	-17.94	-19.27
Change	-	-12.19%	-	-15.05%	-7.4%
Announcement Date	22/03/22	27/04/23	-	-	-

¹USD in Million

Estimates

Forecast Financial Ratios: Evaxion A/S

Fiscal Period: December	2020	2021	2022	2023	2024	2025	2026	2027	2028
Profitability
EBITDA Margin (%)	-	-	-	-	-	-	-	-	-
EBIT Margin (%)	-	-	-	-	-440.55%	-122.66%	-333.11%	-8.89%	-32.16%
EBT Margin (%)	-	-	-	-	-339.56%	-114.44%	-335.9%	-9.46%	-32.85%
Net margin (%)	-	-	-	-	-316%	-102.38%	-329.58%	-9.47%	-43.23%
FCF margin (%)	-	-	-	-	-	-	-393.94%	-105.85%	-120.23%
FCF / Net Income (%)	-	94.7%	112.5%	-	-	-	119.53%	1,117.35%	278.12%
Profitability
ROA	-89.85%	-61.95%	-50.78%	-79.47%	-72.57%	-28.23%	-	-	-
ROE	-183.15%	-124.29%	-113.74%	-1,238.11%	331.2%	-100.18%	-	-	-
Financial Health
Leverage (Debt/EBITDA)	-	-	-	-	-	-	-	-	-
Debt / Free cash flow	-	-	-	-	-	-	-	-	-
Capital Intensity
CAPEX / Current Assets (%)	-	-	-	-	-	-	-	-	-
CAPEX / EBITDA (%)	-	-5.1%	-1.19%	-	-	-	-	-	-
CAPEX / FCF (%)	-	-5.6%	-1.12%	-	-	-	-	-	-
Items per share
Cash flow per share ¹	-	-	-	-	-	-	-2.14	-1.87	-1.81
Change	-	-	-	-	-	-	-	12.62%	3.21%
Dividend per Share ¹	-	-	-	-	-	-	-	-	-
Change	-	-	-	-	-	-	-	-	-
Book Value Per Share ¹	-	-	-	-	-	-	-	-	-
Change	-	-	-	-	-	-	-	-	-
EPS ¹	-	-63	-49	-40.5	-0.2	-0.02	-0.01	0.04	0.005
Change	-	-	22.22%	17.35%	99.51%	90%	50%	500%	-87.5%
Nbr of stocks (in thousands)	-	463	483	758	1,173	8,340	8,340	8,340	8,340
Announcement Date	-	22/03/22	27/04/23	26/03/24	01/04/25	05/03/26	-	-	-